Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Utility of Leflunomide in the Treatment of Drug Resistant Cytomegalovirus Retinitis.

Ocular immunology and inflammation - 1 Feb 2017

Rifkin Lana M, Minkus Caroline L, Pursell Kenneth, Jumroendararasame Chaisiri, Goldstein Debra A

Abstract excerpt

PURPOSE: To describe leflunomide use in the treatment of drug resistant cytomegalovirus retinitis. Leflunomide has been shown to be effective in the treatment of systemic CMV viremia. METHODS: Retrospective chart review of patients with CMV retinitis treated with leflunomide. RESULTS: Two HIV-negative organ transplant recipients with UL 97 mutation resistant-genotype CMV were identified. Patient 1 developed CMV...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Administration, Oral
Share to Cytomegalovirus

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunosuppressive Agents

Share to Intravitreal Injections

Share to Isoxazoles

Share to Kidney Transplantation

Share to Lung Transplantation

Share to Viremia

Source

Identifiers

PMID: 26652481
DOI: 10.3109/09273948.2015.1071406

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Utility of Leflunomide in the Treatment of Drug Resistant Cytomegalovirus Retinitis.PMID 26652481Read ↗

Leflunomide therapy for refractory cytomegalovirus infections in hematopoietic stem cell transplant recipients.Semantic proximity Read ↗

Use of high-dose ganciclovir for a resistant cytomegalovirus infection due to UL97 mutation.Semantic proximity Read ↗

Genotypic analysis of cytomegalovirus retinitis poorly responsive to intravenous ganciclovir but responsive to the ganciclovir implant.Semantic proximity Read ↗

Approach to drug-resistant cytomegalovirus in transplant recipients.Semantic proximity Read ↗

Resistance of human cytomegalovirus to antiviral drugs.Semantic proximity Read ↗

Mutations conferring ganciclovir resistance in a cohort of patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis.Semantic proximity Read ↗

Antiviral drug resistance in human cytomegalovirus.Semantic proximity Read ↗

Ganciclovir-resistant cytomegalovirus encephalitis in a hematopoietic stem cell transplant recipient.Semantic proximity Read ↗

Mutations in the cytomegalovirus UL97 gene associated with ganciclovir-resistant retinitis.Semantic proximity Read ↗

Recurrent CMV retinitis in a non-HIV patient with drug-resistant CMV.Semantic proximity Read ↗

Longitudinal observations on mutations conferring ganciclovir resistance in patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis: The Cytomegalovirus and Viral Resistance Study Group Report Number 8.Semantic proximity Read ↗

A single-center experience with ganciclovir-resistant cytomegalovirus in lung transplant recipients: treatment and outcome.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.